SCHEMBL5834646

SCHEMBL5834646

C/C=C\CC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36817 1.00
SCHEMBL36816 1.00
Water SCHEMBL11057353 0.97
Water SCHEMBL11057357 0.97
SCHEMBL23434850 0.86 TSHR (0.44)
SCHEMBL17399524 0.86 TSHR (0.44)
SCHEMBL16093126 0.86 TSHR (0.44)
SCHEMBL821076 0.86 TSHR (0.53)
SCHEMBL869082 0.86 TSHR (0.53)
SCHEMBL869080 0.86 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174477-A1 METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER PURDUE RESEARCH FOUNDATION 2023-06-08 US disclosed
US-8039670-B2 Analogs of alpha galactosyceramide and uses thereof LUDWIG INSTITUTE FOR CANCER RESEARCH (US) 2011-10-18 US disclosed
US-20090239813-A1 Analogs of Alpha Galactosyceramide and Uses thereof LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) 2009-09-24 US disclosed
CN-1297562-C Diphosphine BASF AG (DE) 2007-01-31 CN disclosed
US-7105689-B2 Compound suitable for use as a catalyst or for producing a catalyst system derived from a bis-phosphorinane BASF AKTIENGESELLSCHAFT (DE) 2006-09-12 US disclosed
US-7074965-B2 a multidentate organic phosphorous ligand for preparing alkenecarboxylic acid derivatives by carbonylation of conjugated dienes in the presence of a hydroxyl-containing compound in the liquid phase in the presence of a carbonylation catalyst that comprises a palladium compound BASF AKTIENGESELLSCHAFT (DE) 2006-07-11 US disclosed
WO-2006011024-A9 NEW TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD (IN) 2006-06-08 WO disclosed
US-6844463-B2 Method for the carbonylation of pentenoic acid and its derivatives thereof BASF AKTIENGESELLSCHAFT (DE) 2005-01-18 US disclosed
US-20040249216-A1 Diphosphine BASF AKTIENGESELLSCHAFT (DE) 2004-12-09 US disclosed
US-20040110989-A1 Method for the carbonylation of pentenoic acid and its derivatives thereof BASF AKTIENGESELLSCHAFT (DE) 2004-06-10 US disclosed
EP-0715616-B1 PROCESS FOR THE PREPARATION OF A MIXTURE OF ALKYL PENTENOATES DSM NV (NL) 1998-06-03 EP disclosed
US-5693851-A CARBONYLATION OF BUTADIENE IN THE PRESENCE OF AN ALKANOL, CARBON MONOXIDE, PALLADIUM AND A BIDENTE LIGAND-CONTAINING COORDINATION COMPOUND OF A TRANSITION METAL DSM N.V. (NL) 1997-12-02 US disclosed
WO-1997006126-A1 PROCESS FOR THE CONTINUOUS PREPARATION OF PURE 5-FORMYL VALERIC ACID ESTERS BASF AKTIENGESELLSCHAFT (DE) 1997-02-20 WO disclosed
EP-0715616-A1 PROCESS FOR THE PREPARATION OF A MIXTURE OF ALKYL PENTENOATES DSM N.V. (NL) 1996-06-12 EP disclosed
WO-1995006027-A1 PROCESS FOR THE PREPARATION OF A MIXTURE OF ALKYL PENTENOATES DSM N.V. (NL) 1995-03-02 WO disclosed
US-4906769-A Isomerization of 2-pentenoates to 3-pentenoates BASF AKTIENGESELLSCHAFT (DE) 1990-03-06 US disclosed
US-4874889-A TREATING WITH CYCLIC TERTIARY AMINE BASF AKTIENGESELLSCHAFT (DE) 1989-10-17 US disclosed
EP-0306875-A2 Process for the preparation of 5-methyl butyrolactone BASF Aktiengesellschaft (DE) 1989-03-15 EP disclosed
US-4801738-A ISOMERIZATION OF 3-PENTENOATE, GROUP 8 ACID CATALYST, HYDROFORMYLATION, RHODIUM CARBONYL COMPLEX BASF AKTIENGESELLSCHAFT (DE) 1989-01-31 US disclosed
EP-0126349-B1 PROCESS FOR THE PREPARATION OF 4-PENTENOIC-ACID ESTERS BASF Aktiengesellschaft (DE) 1986-08-20 EP disclosed